Assay method demonstrates precision and accuracy for estimating gliclazide and dapagliflozin in tablets, indicating its effectiveness for quality control.
Key Points
The RP HPLC method successfully estimates gliclazide and dapagliflozin in tablet formulations.
Linearity was confirmed with R² values of 0.996 for gliclazide and 0.9963 for dapagliflozin.
The method achieved acceptable levels of accuracy and precision across specified concentration ranges.
Validation highlighted the method's robustness for quality control in pharmaceutical formulations.